Wolverine Asset Management
DMIIR icon

Wolverine Asset Management’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

Wolverine Asset Management’s Portfolio DMIIR Stock Details DMIIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$31.4K Sell
489,607
-9,750
-2% -$760 ﹤0.01% 1380
2026
Q2 		$39.9K Sell
499,357
-3,700
-0.7% -$316 ﹤0.01% 1286
2026
Q1 		$40.2K Sell
503,057
-2,000
-0.4% -$227 ﹤0.01% 1281
2025
Q4 		$70.7K Buy
+505,057
New +$72.1K ﹤0.01% 1233

Other funds holding DMIIR

Picton Mahoney Asset Management
Picton Mahoney Asset Management Toronto, Ontario, Canada $14.8B AUM 38.11% 1-Year Est. Return
Context Capital Management
Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return
Wealthspring Capital
Wealthspring Capital West Harrison, New York $447M AUM 5.09% 1-Year Est. Return
Commonwealth of Pennsylvania Public School Employees Retirement System
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $21.9B AUM 28.42% 1-Year Est. Return
Periscope Capital
Periscope Capital Toronto, Ontario, Canada $990M AUM 4.73% 1-Year Est. Return
Mint Tower Capital Management
Mint Tower Capital Management Amsterdam, Netherlands $589M AUM 6.02% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
ABC Arbitrage
ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return

Wolverine Asset Management's DMIIR Position: Q3 2026 in Review

Wolverine Asset Management reduced its Drugs Made In America Acquisition II Corp Right (DMIIR) stake by 2% in Q3 2026, selling an estimated $760 and leaving 489,607 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1380.

Wolverine Asset Management first reported a position in DMIIR in Q4 2025 and has held it in 4 quarters since. The position peaked at $70.7K in Q4 2025. 9 funds tracked by Wall St. Rank hold DMIIR as of Q3 2026.

  • Wolverine Asset Management held 489,607 shares of Drugs Made In America Acquisition II Corp Right worth $31.4K as of Q3 2026.
  • Wolverine Asset Management sold 9,750 Drugs Made In America Acquisition II Corp Right shares in Q3 2026, an estimated $760.
  • Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of Wolverine Asset Management's portfolio in Q3 2026, its #1380 holding.
  • Wolverine Asset Management first reported a position in Drugs Made In America Acquisition II Corp Right in Q4 2025 and has held it in 4 quarters since.
  • Wolverine Asset Management's Drugs Made In America Acquisition II Corp Right position peaked at $70.7K in Q4 2025.
  • 9 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q3 2026.

Based on Wolverine Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.